Alerce Investment Management, L.P. - Q2 2023 holdings

$76.9 Million is the total value of Alerce Investment Management, L.P.'s 6 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .

 Value Shares↓ Weighting
ANNX  ANNEXON INC$24,837,204
-8.6%
7,056,0240.0%32.31%
-10.0%
AMWL  AMERICAN WELL CORPcl a$21,999,006
-11.0%
10,475,7170.0%28.62%
-12.4%
AKBA  AKEBIA THERAPEUTICS INC$14,827,684
+63.3%
16,205,1190.0%19.29%
+60.8%
 AADI BIOSCIENCE INC$11,154,877
-5.5%
1,630,8300.0%14.51%
-7.0%
ASMB  ASSEMBLY BIOSCIENCES INC$2,561,625
+36.8%
2,227,5000.0%3.33%
+34.7%
 AILERON THERAPEUTICS INC$1,486,534
+44.4%
830,4660.0%1.93%
+42.1%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-14
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AMERICAN WELL CORP12Q3 202362.9%
ANNEXON INC12Q3 202335.9%
AKEBIA THERAPEUTICS INC12Q3 202331.6%
ASSEMBLY BIOSCIENCES INC12Q3 20238.7%
AADI BIOSCIENCES INC9Q3 202324.1%
AILERON THERAPEUTICS INC8Q3 202214.4%
GLOBAL BLOOD THERAPEUTICS IN8Q3 202223.4%
AILERON THERAPEUTICS INC4Q3 20232.3%
AERPIO PHARMACEUTICALS INC3Q2 20215.2%

View Alerce Investment Management, L.P.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-09
13F-HR2024-02-09
13F-HR2023-11-13
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-04
13F-HR2022-05-13
13F-HR2022-02-09

View Alerce Investment Management, L.P.'s complete filings history.

Compare quarters

Export Alerce Investment Management, L.P.'s holdings